Analyst Ratings for Radient Pharmaceuticals (RPC)
RPC Rating Summary
RPC Price Target Summary
- Highest: $16.00 (Oppenheimer)
- Lowest: $11.00 (Barclays)
- Average: $12.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$12.67 (+43.1%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/13/2017 | BMO Capital | N/A | New Coverage | Outperform (N/A) |
24.00 (N/A) |
0.21 (8.85) |
4114.29% | Details |
| 10/7/2010 | CapitalOne | N/A | New Coverage | Overweight (N/A) |
N/A (N/A) |
0.68 (8.85) |
1201.47% | Details |
